These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 9414288)

  • 1. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
    Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
    Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T cells activated during the course of murine acute myelogenous leukemia elicit therapeutic responses to late B7 vaccines after cytoreductive treatment.
    Dunussi-Joannopoulos K; Krenger W; Weinstein HJ; Ferrara JL; Croop JM
    Blood; 1997 Apr; 89(8):2915-24. PubMed ID: 9108412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy with B7.1 and GM-CSF vaccines in a murine AML model.
    Dunussi-Joannopoulos K; Weinstein HJ; Arceci RJ; Croop JM
    J Pediatr Hematol Oncol; 1997; 19(6):536-40. PubMed ID: 9407942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses.
    Stripecke R; Cardoso AA; Pepper KA; Skelton DC; Yu XJ; Mascarenhas L; Weinberg KI; Nadler LM; Kohn DB
    Blood; 2000 Aug; 96(4):1317-26. PubMed ID: 10942373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses.
    Runyon K; Lee K; Zuberek K; Collins M; Leonard JP; Dunussi-Joannopoulos K
    Blood; 2001 Apr; 97(8):2420-6. PubMed ID: 11290606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells.
    Boyer MW; Waller EK; Bray RA; Unangst T; Johnson TS; Phillips C; Jurickova I; Winton EF; Yeager AM
    Leukemia; 2000 Mar; 14(3):412-8. PubMed ID: 10720135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S
    Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.
    Mutis T; Schrama E; Melief CJ; Goulmy E
    Blood; 1998 Sep; 92(5):1677-84. PubMed ID: 9716596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of acute passive murine encephalomyelitis II. Th1 phenotype of the inducing population is not sufficient to cause disease.
    Lyons JA; Zhao ML; Fritz RB
    J Neuroimmunol; 1999 Jan; 93(1-2):26-36. PubMed ID: 10378866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
    Re F; Arpinati M; Testoni N; Ricci P; Terragna C; Preda P; Ruggeri D; Senese B; Chirumbolo G; Martelli V; Urbini B; Baccarani M; Tura S; Rondelli D
    Exp Hematol; 2002 Feb; 30(2):126-34. PubMed ID: 11823047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Stripecke R; Skelton DC; Pattengale PK; Shimada H; Kohn DB
    Hum Gene Ther; 1999 Sep; 10(13):2109-22. PubMed ID: 10498243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of B7-1 in mediating an immune response to myeloid leukemia cells.
    Matulonis UA; Dosiou C; Lamont C; Freeman GJ; Mauch P; Nadler LM; Griffin JD
    Blood; 1995 May; 85(9):2507-15. PubMed ID: 7537118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
    Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
    Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
    Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
    Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.